Market Cap 85.84M
Revenue (ttm) 0.00
Net Income (ttm) -36.73M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 419,100
Avg Vol 452,540
Day's Range N/A - N/A
Shares Out 17.66M
Stochastic %K 79%
Beta 1.86
Analysts Strong Sell
Price Target $35.14

Company Profile

Unicycive Therapeutics, Inc., a clinical-stage biotechnology company, identifies, develops, and commercializes therapies to address unmet medical needs in the United States. Its drug candidates include UNI 494, a pro-drug of Nicorandil that is being developed as a treatment for acute kidney injury; and Renazorb RZB 012 for the treatment of hyperphosphatemia in patients with chronic kidney disease. The company also evaluates licensing of technologies and drugs for orphan diseases, other renal, li...

Industry: Biotechnology
Sector: Healthcare
Phone: 650 351 4495
Address:
4300 El Camino Real, Suite 210, Los Altos, United States
Loafyloaf
Loafyloaf Oct. 24 at 10:58 PM
$UNCY Nice close for a Friday. Take the creep upward as a positive sign until news proves otherwise. Good luck to the patient longs.
0 · Reply
2stockshackur
2stockshackur Oct. 24 at 3:08 PM
$UNCY Today might be the day they drop bad news. I haven’t been trusting these slow price increase on low volume with news being delayed so long
1 · Reply
dcajic2
dcajic2 Oct. 24 at 2:28 PM
$UNCY Just be patient. I think once the government opens up again this stock will see a higher stock price. 40% of the FDA is furloughed.
1 · Reply
zawojak
zawojak Oct. 23 at 10:03 PM
$UNCY the low volume means its a POS stock for everyone, yet I am still holding.
1 · Reply
Greenbackisback
Greenbackisback Oct. 23 at 1:04 AM
$UNCY with the recent lawsuits against them they are probably be more cautious about any statements they make right now. I am heavy on them as well as I think this is they have a great opportunity here.
2 · Reply
Hstar
Hstar Oct. 22 at 11:41 PM
$UNCY I have a sizeable allocation in the stock and continue to hold because I believe they have a real shot at a win here. That said, this company is a case study in how not to run a public company. Communication is key and unfortunately, they’ve failed investors on multiple occasions. A simple update could go a long way in maintaining confidence. Something along the lines of: “We submitted the request for a Type A meeting on [xx/xx/xxxx] and are awaiting a response. Due to [reason], the response has been delayed, but we will provide an update as soon as we receive [next step].” Whoever is advising them on PR is doing a poor job, and the CEO has been a disappointment. Gupta needs to move past the “why this drug is important” to actually making sh* happen. I hope someone at the company takes note of this.
3 · Reply
King_of_Bio
King_of_Bio Oct. 22 at 2:03 PM
0 · Reply
bankrupt_bob
bankrupt_bob Oct. 22 at 5:04 AM
$UNCY Despite the partial government shutdown, the FDA does not stop working completely, but operations narrow. Roughly 85% of staff continue working, supported by carryover user fees. The article below explains more. https://www.caidya.com/navigating-fda-regulatory-challenges-during-a-u-s-government-shutdown/
0 · Reply
Greenbackisback
Greenbackisback Oct. 21 at 3:17 PM
0 · Reply
King_of_Bio
King_of_Bio Oct. 21 at 2:22 PM
0 · Reply
Latest News on UNCY
Unicycive Therapeutics, Inc. Announces Reverse Stock Split

Jun 17, 2025, 7:00 AM EDT - 4 months ago

Unicycive Therapeutics, Inc. Announces Reverse Stock Split


Loafyloaf
Loafyloaf Oct. 24 at 10:58 PM
$UNCY Nice close for a Friday. Take the creep upward as a positive sign until news proves otherwise. Good luck to the patient longs.
0 · Reply
2stockshackur
2stockshackur Oct. 24 at 3:08 PM
$UNCY Today might be the day they drop bad news. I haven’t been trusting these slow price increase on low volume with news being delayed so long
1 · Reply
dcajic2
dcajic2 Oct. 24 at 2:28 PM
$UNCY Just be patient. I think once the government opens up again this stock will see a higher stock price. 40% of the FDA is furloughed.
1 · Reply
zawojak
zawojak Oct. 23 at 10:03 PM
$UNCY the low volume means its a POS stock for everyone, yet I am still holding.
1 · Reply
Greenbackisback
Greenbackisback Oct. 23 at 1:04 AM
$UNCY with the recent lawsuits against them they are probably be more cautious about any statements they make right now. I am heavy on them as well as I think this is they have a great opportunity here.
2 · Reply
Hstar
Hstar Oct. 22 at 11:41 PM
$UNCY I have a sizeable allocation in the stock and continue to hold because I believe they have a real shot at a win here. That said, this company is a case study in how not to run a public company. Communication is key and unfortunately, they’ve failed investors on multiple occasions. A simple update could go a long way in maintaining confidence. Something along the lines of: “We submitted the request for a Type A meeting on [xx/xx/xxxx] and are awaiting a response. Due to [reason], the response has been delayed, but we will provide an update as soon as we receive [next step].” Whoever is advising them on PR is doing a poor job, and the CEO has been a disappointment. Gupta needs to move past the “why this drug is important” to actually making sh* happen. I hope someone at the company takes note of this.
3 · Reply
King_of_Bio
King_of_Bio Oct. 22 at 2:03 PM
0 · Reply
bankrupt_bob
bankrupt_bob Oct. 22 at 5:04 AM
$UNCY Despite the partial government shutdown, the FDA does not stop working completely, but operations narrow. Roughly 85% of staff continue working, supported by carryover user fees. The article below explains more. https://www.caidya.com/navigating-fda-regulatory-challenges-during-a-u-s-government-shutdown/
0 · Reply
Greenbackisback
Greenbackisback Oct. 21 at 3:17 PM
0 · Reply
King_of_Bio
King_of_Bio Oct. 21 at 2:22 PM
0 · Reply
dcajic2
dcajic2 Oct. 21 at 2:05 PM
$UNCY adding a few. The fda is basically shut down and could be shut down for an extended period of time.
1 · Reply
Vibration
Vibration Oct. 21 at 1:34 PM
$UNCY something looks like happening!
0 · Reply
Hstar
Hstar Oct. 18 at 3:18 AM
$UNCY they just hired VP of Biz Commercial Operations. Dude has good product launch experience. Given timing of hire it definitely signals potential for a near-term positive outcome.
2 · Reply
zawojak
zawojak Oct. 17 at 1:38 PM
$UNCY I am really concerned about the yesterday's spike to over 5.30. Thats a bad news imo.
1 · Reply
zawojak
zawojak Oct. 16 at 6:32 PM
$UNCY this spike to $5.34 today looked like someone has pumped so other can exit kind of thing. Smh
1 · Reply
Greenbackisback
Greenbackisback Oct. 16 at 3:49 PM
3 · Reply
Yanpet2015
Yanpet2015 Oct. 16 at 2:53 PM
$UNCY ,sell or waite 🧐
2 · Reply
Greenbackisback
Greenbackisback Oct. 16 at 2:31 PM
$UNCY Well now- lets see what this girl can do.
2 · Reply
makedatbread88
makedatbread88 Oct. 16 at 2:22 PM
$UNCY I said it’s been heavily accumulated! ***Follow me for more winning calls!***
1 · Reply
2stockshackur
2stockshackur Oct. 16 at 2:21 PM
$IXHL $UNCY Gotta do a lil repost lol.
1 · Reply
King_of_Bio
King_of_Bio Oct. 16 at 2:17 PM
0 · Reply
dcajic2
dcajic2 Oct. 16 at 1:47 PM
$UNCY I have been patient and have been holding. Anyone know why we are goi NG higher. Fda is going to be very slow with governments shutdown
0 · Reply